Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Combination of Lenalidomide and Dexamethasone in Treatment of Multiple Myeloma (DSM XIII)

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2014 by Gesellschaft fur Medizinische Innovation – Hamatologie und Onkologie mbH
Sponsor:
Collaborator:
ClinAssess GmbH
Information provided by (Responsible Party):
Gesellschaft fur Medizinische Innovation – Hamatologie und Onkologie mbH
ClinicalTrials.gov Identifier:
NCT01090089
First received: March 18, 2010
Last updated: June 17, 2014
Last verified: June 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: April 2015
  Estimated Primary Completion Date: January 2015 (Final data collection date for primary outcome measure)